Kara Carter
Impact in
- Oncology top 10%
- Viral-associated cancers and disorders
- Peptidase Inhibition and Analysis
-
- Cancer Mechanisms and Therapy
- Lymphoma Diagnosis and Treatment
Papers in
-
- Herpesvirus Infections and Treatments 3
- Cytomegalovirus and herpesvirus research 3
- Hepatitis B Virus Studies 2
- Influenza Virus Research Studies 2
-
- interferon and immune responses 3
- T-cell and Retrovirus Studies 2
- Co-authors
- Elliott Kieff (4 shared papers)Ellen Cahir-McFarland (2 shared papers)Louis M. Staudt (1 shared paper)Jena M. Giltnane (1 shared paper)Andreas Rosenwald (1 shared paper)Sarah E. Henrickson (1 shared paper)Nisse Kalkkinen (1 shared paper)Olli Silvennoinen (1 shared paper)
- Journals
- Antiviral Research (6 papers)Journal of Hepatology (2 papers)Journal of Virology (2 papers)Virology (2 papers)Antiviral chemistry & chemotherapy (1 paper)
- Partner nations
- United StatesFranceBelgium
In The Last Decade
Kara Carter
17 papers receiving 817 citations
Peers
Comparison fields: 5 of 77
- Oncology 306
- Pathology and Forensic Medicine 198
- Virology 53
- Immunology 219
- Epidemiology 232
Countries citing papers authored by Kara Carter
This map shows the geographic impact of Kara Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kara Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kara Carter more than expected).
Fields of papers citing papers by Kara Carter
This network shows the impact of papers produced by Kara Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kara Carter. The network helps show where Kara Carter may publish in the future.
Co-authors
The 25 scholars most cited alongside Kara Carter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 196 | |
| 2 | 2002 | 152 | |
| 3 | 2002 | 127 | |
| 4 | 2020 | 61 | |
| 5 | 2002 | 59 | |
| 6 | 1997 | 56 | |
| 7 | 2009 | 54 | |
| 8 | 2022 | 31 | |
| 9 | 2005 | 30 | |
| 10 | 2020 | 26 | |
| 11 | 2017 | 10 | |
| 12 | 2018 | 8 | |
| 13 | 2022 | 7 | |
| 14 | 2022 | 5 | |
| 15 | 2020 | 3 | |
| 16 | 2022 | 3 | |
| 17 | 2023 | 1 | |
| 18 | 2024 | 0 |
About Kara Carter
Kara Carter is a scholar working on Epidemiology, Immunology, Oncology, Infectious Diseases and Molecular Biology, having authored 18 papers that have together received 829 indexed citations. Recurring topics across this work include interferon and immune responses (3 papers), Herpesvirus Infections and Treatments (3 papers), Cytomegalovirus and herpesvirus research (3 papers), Mosquito-borne diseases and control (3 papers), Hepatitis B Virus Studies (2 papers), Viral-associated cancers and disorders (2 papers), T-cell and Retrovirus Studies (2 papers) and Influenza Virus Research Studies (2 papers). The work is most often cited by research in Oncology (306 citations), Pathology and Forensic Medicine (198 citations), Virology (53 citations), Immunology (219 citations) and Epidemiology (232 citations). Kara Carter has collaborated with scholars based in United States, France and Belgium. Frequent co-authors include Elliott Kieff, Ellen Cahir-McFarland, Louis M. Staudt, Jena M. Giltnane, Andreas Rosenwald, Sarah E. Henrickson, Nisse Kalkkinen, Olli Silvennoinen, Jie Yang and Marko Pesu. Their work appears in journals such as Antiviral Research, Journal of Hepatology, Journal of Virology, Virology and Antiviral chemistry & chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.